Search

everythinglearnresearchcommunity

for

Search:↓

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Targeting PTEN can improve healing in venous leg ulcers.

A specific enzyme that activates the hair growth medication minoxidil when applied to the skin was identified.

Sgk3 is essential for normal hair follicle growth and maintenance.

Minoxidil sulfate and pinacidil may promote hair growth through increased blood flow, not by activating potassium channels.

5αR inhibitors help slow early prostate cancer cell growth, suggesting combined treatments are needed.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

A new engineered treatment shows promise in curing heart fibrosis.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Potassium channel openers can boost hair growth by stimulating DNA in hair follicles.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

KF19418 promotes hair growth similarly to minoxidil but is not better in live mice.

A hemodialysis patient's hair loss was caused by the drug tinzaparin but stopped after switching to a different drug.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.